Pharmaceutical Industry Information Portal

HomeNews

News

Nacimbio is Launching a New Drug for the Treatment of Immunodeficiencies

NPO Microgen, a company of the Naimbio holding, is launching on the market the first domestic human normal immunoglobulin for intravenous administration in the...

Pharmtech & Ingredients International Exposition 2022 Results

The 24th Pharmtech & Ingredients International Exposition of Equipment, Raw Materials and Technologies for Pharmaceutical Industry was held on 22-25 November 2022. It was...

Pharmstandard will construct a new production facility in Ufa

The investment project will be implemented in 2023–2025. The total amount of investment is estimated to be 2.6 billion rubles. According to Nail Nizamutdinov, General...

Binnopharm Group brings its popular antispasmodic to Azerbaijan

Binnopharm Group, a pharmaceutical company and part of Sistema, continues to expand its footprint in the CIS markets. Neobutin, an antispasmodic with prokinetic effect...

Vladimir Shipkov: Foreign pharmaceutical companies continue to supply medicines to Russia

Foreign pharmaceutical companies continue to work in Russia and supply medicines to the Russian market, Executive Director of the Association of International Pharmaceutical Manufacturers...

Petrovax began supplying quadrivalent influenza vaccine to the Russian market and abroad

The total supply of the vaccine for Russian and foreign markets in 2022 will amount to more than 2.5 million doses
spot_img

Expert Articles

spot_img